Ergothioneine (L-Ergo) is a longevity product whose active basis is plasma ergothioneine, cytoprotection. Higher plasma ergothioneine tracks lower disease risk. It is positioned for resale to the growing healthspan-focused consumer market.
Marker linked to reduced cardiometabolic mortality. Research relevant to this mechanism is indexed on PubMed and linked below; it describes the mechanism rather than this specific product.
Peer-reviewed studies on the active compound — citations link to PubMed.
“higher ergothioneine was an independent marker of lower risk of cardiometabolic disease and mortality”
“Ingestion of ergothioneine remarkably extended the lifespan of male mice and rescued age-related impairments”
“high plasma ergothioneine levels associated with reduced overall mortality”
Research describes the active mechanism and is not a claim about this specific product.
Slightly reduces coronary mortality and events. Research relevant to this mechanism is…
Counters sarcopenia, frailty and bone loss in aging. Research relevant to this mechanism…
Counters oxidative stress accumulating with age. Research relevant to this mechanism is…
Maintains immune competence across the lifespan. Research relevant to this mechanism is…
Yes — its active compound is linked to 3 peer-reviewed studies, summarized and cited above.
You can buy it on Amazon via the link above; Magellan earns a small affiliate commission at no extra cost to you, which does not affect the evidence grade.
Dietary supplements and devices are generally well tolerated but are not a substitute for medical care. Talk to your physician before starting, especially if you take medication or have a health condition.